Capitalizing on AI to CapTure Undiagnosed Structural Heart Disease
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 4000 participants.
Also called NCT07843004
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose screening
- Phase
- Not applicable
- Enrolled
- 4,000 participants
- Registry
-
NCT07843004
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT07843004. Randomized; no masking; primary purpose screening. Start 2026-09-16 (actual); primary completion 2027-06-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Capitalizing on AI to CapTure Undiagnosed Structural Heart Disease
- Acronym
- CACTUS
- Condition
- Structural Heart Abnormality
- Condition
- Valve Heart Disease
- Condition
- Heart Diseases
- Condition
- Cardiovascular Diseases
- Intervention (Device)
- EHR Alert
- Lead sponsor
- Pierre Elias
- Collaborator
- Edwards Lifesciences
- Collaborator
- National Heart, Lung, and Blood Institute (NHLBI)
Record details
- Record id
cardio:ct-nct07843004- Content hash
431f9e455cde5288936619bbf56c136a2fa188c568942ed2e7fb1fb78c299f7b